EVEREST MED (01952) announced that the company's board of directors has been informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a major shareholder of the company. On May 14, 2026, Mr. Fu, through a company under his control, purchased 660,000 ordinary shares of the company in the market, with a total consideration of approximately HKD 20.7 million and an average price of about HKD 31.25 per share. According to Mr. Fu, his acquisition of shares through on-market purchases is based on his firm confidence in the company's future prospects and long-term development. Subject to compliance with applicable laws and regulations, Mr. Fu does not rule out the possibility of further increasing his holdings in the company at an appropriate time.